Lv4
498 积分 2023-09-11 加入
The critical role of discoidin domain receptors in the regulation of anti-tumor immune responses
14天前
已完结
Antibody-drug conjugates targeting DDR1 as a novel strategy for treatment of breast cancer
15天前
已完结
Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeks
15天前
已关闭
DDR1-targeted therapies: current limitations and future potential
15天前
已完结
Design, Synthesis, and Biological Evaluation of Selective PAK4 Degrader for the Treatment of Lung Tumor Metastasis
16天前
已完结
Targeted therapy for DNA damage response and homologous recombination repair defects: The Olaparib Combinations trial
24天前
已完结
Frequency of human anti-FVIII antibodies in humanized SCID mice elicited by recombinant deleted factor VIII and by a plasma derived factor VIII
1个月前
已完结
CpG adjuvant enhances humoral and cellular immunity against OVA in different degrees in BALB/c, C57BL/6J, and C57BL/6N mice
1个月前
已完结
Treatment of Advanced BRAF-Mutated Colorectal Cancer: Where We Are and Where We Are Going
1个月前
已完结
A BRAF new world
1个月前
已完结
皖公网安备34019202002308
